Danaher Discloses Senior Note Details in 8-K Filing

TL;DR

**Danaher just updated its debt profile, showing various senior notes with maturities stretching to 2049.**

AI Summary

Danaher Corporation filed an 8-K on January 8, 2024, to report on its financial condition and operations, specifically regarding various senior notes. The filing details several series of senior notes with different interest rates and maturity dates, including 1.7% Senior Notes due 2024, 0.2% Senior Notes due 2026, and 1.8% Senior Notes due 2049. This matters to investors because it provides transparency into Danaher's debt structure, which can impact its financial flexibility and future earnings, especially as some notes mature soon.

Why It Matters

Understanding Danaher's debt obligations, including interest rates and maturity dates, is crucial for investors to assess the company's financial health and future cash flow commitments.

Risk Assessment

Risk Level: low — This 8-K filing is purely informational, detailing existing debt instruments, and does not indicate new risks or significant changes to the company's financial standing.

Analyst Insight

A smart investor would review Danaher's upcoming earnings reports for details on how the company plans to manage the repayment or refinancing of its 1.7% Senior Notes due in 2024, as this could impact short-term cash flow.

Key Numbers

• 1.7% — Interest Rate (Senior Notes due 2024)
• 0.2% — Interest Rate (Senior Notes due 2026)
• 2.1% — Interest Rate (Senior Notes due 2026)
• 1.2% — Interest Rate (Senior Notes due 2027)
• 0.45% — Interest Rate (Senior Notes due 2028)
• 2.5% — Interest Rate (Senior Notes due 2030)
• 0.75% — Interest Rate (Senior Notes due 2031)
• 1.35% — Interest Rate (Senior Notes due 2039)

Key Players & Entities

• DANAHER CORPORATION (company) — the registrant filing the 8-K
• Delaware (company) — state of incorporation for Danaher Corporation
• Washington, D.C. (company) — location of Danaher Corporation's principal executive offices
• 001-08089 (dollar_amount) — Commission File Number
• 59-1995548 (dollar_amount) — IRS Employer Identification No.
• 202-828-0850 (dollar_amount) — Registrant's Telephone Number

Forward-Looking Statements

• Danaher will likely refinance or repay the 1.7% Senior Notes due 2024 as they approach maturity. (DANAHER CORPORATION) — high confidence, target: 2024-12-31
• The company's interest expense will remain relatively stable in the short term given the varied maturity dates of its senior notes. (DANAHER CORPORATION) — medium confidence, target: 2025-01-08

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value DHR New York Stock Exchange

Filing Documents

• dhr-20240108.htm (8-K) — 44KB
• dhr-20240108xex991.htm (EX-99.1) — 21KB
• ex991pre-selecteddanaher.htm (EX-99.1PRE) — 10KB
• dhr-20240108_g1.jpg (GRAPHIC) — 8KB
• dhrlogoa.jpg (GRAPHIC) — 8KB
• ex991pre-selecteddanaher001.jpg (GRAPHIC) — 266KB
• ex991pre-selecteddanaher002.jpg (GRAPHIC) — 168KB
• ex991pre-selecteddanaher003.jpg (GRAPHIC) — 95KB
• ex991pre-selecteddanaher004.jpg (GRAPHIC) — 114KB
• ex991pre-selecteddanaher005.jpg (GRAPHIC) — 100KB
• 0000313616-24-000004.txt ( ) — 1356KB
• dhr-20240108.xsd (EX-101.SCH) — 5KB
• dhr-20240108_def.xml (EX-101.DEF) — 11KB
• dhr-20240108_lab.xml (EX-101.LAB) — 41KB
• dhr-20240108_pre.xml (EX-101.PRE) — 20KB
• dhr-20240108_htm.xml (XML) — 10KB

02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 8, 2024, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on January 9, 2024 Danaher Corporation issued a press release regarding the Company's anticipated financial performance for the fourth quarter of 2023 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher's anticipated financial performance for 2023. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits: Exhibit No. Description 99.1 Press release — "Danaher CEO to Comment on Financial Performance" 99.1PRE Selected Danaher Presentation Slides for J.P. Morgan Healthcare Conference on January 9, 2024 104 The cover page from this Current Report on Form 8-K, formatted as Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DANAHER CORPORATION Date: January 8, 2024 By: /s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR